跳至主要内容
临床试验/CTRI/2023/05/052160
CTRI/2023/05/052160已完成3 期

A Randomized, Multi-Centric, Open Label, Comparative, Clinical Study To Evaluate The Efficacy and Safety Of Trumove Gel In Patients with Musculo-Skeletal and Joint Pain

Tirupati Pharma, India2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年5月5日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
3. Time to achieve complete relief of pain

研究概览

简要总结

  • The subjects who fulfilled the inclusion and exclusion criteria will be enrolled in the study.
  • 30 Participants will be randomized into 2 groups with 15 in each group.
  • Arm 1 - Trumove Gel: 15 study participants
  • Arm 2 - Volitra Gel: 15 study participants

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Patients of either sex aged above 18 years.
  • Patients who are able to understand written and/or verbal instructions and are ready to comply with all study requirements with a willingness to participate and give written informed consent voluntarily.
  • Patients who had been diagnosed with acute and chronic localized musculoskeletal pain and joint pain (arthritis) .

排除标准

  • Women of child bearing potential who are either unwilling or unable to use an acceptable method of birth control to avoid pregnancy during the study period.
  • Subject with active skin lesions or other skin diseases.
  • Subject with history of uncontrolled diabetes
  • Subject with history of Periarthritis, rheumatoid arthritis
  • Known allergy to compounds of investigational product.
  • Participation in an investigational drug trial in the30 days prior to the screeningvisit.
  • Patients of vulnerable group (children, lactating mother, elderly >80 years,handicapped, seriously ill, mentally challenged).
  • History of drug or alcohol abuse during the last 6 months.

结局指标

主要结局

3. Time to achieve complete relief of pain

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

4. Reduction in pain score on numeric pain rating scale AT REST and during MOVEMENT

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

6. Time interval between onset of pain relief and the need for second application of test / comparator product for pain relief

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

7. Subjects overall satisfaction for pain relief on a 7- point Likert Satisfaction scale

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

2. Time to onset of cooling/warmth/tingling/burning sensation

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

1. Time to onset of relief of pain

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

5. Changes in joint/Musculo skeletal pain intensity measured by Pain VAS Scale (0-100 mm)

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

8.User perception was assessed with a 5- point Likert Satisfaction scale

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

9. Number of patients requiring rescue medication

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

10. Changes in C Reactive Protein and ESR

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

11. Changes in Quality of life Questionnaires (Short Form Health-12) and the WOMAC Pain score and McGill Pain Questionnaire for pain intensity.

时间窗: Day 1 [Time frame: 30 seconds, 1 minute, 2 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, 120 minutes and hourly upto 8 hours post dose] , day 7 to day 10

次要结局

  • Adverse events and serious adverse events during the study period(Brief clinical examination)

研究者

发起方
Tirupati Pharma, India
申办方类型
Pharmaceutical industry-Indian

研究点 (2)

Loading locations...

相似试验